Literature DB >> 3113393

[Coronary risk factors. The French paradox].

J L Richard.   

Abstract

Concordant data suggest that the frequency of ischaemic heart diseases in France is relatively moderate and noticeably lower than in most industrial European or English-speaking countries. This fact is documented by mortality statistics and planned surveys (Parisian Prospective Study, Records, ENIM). This peculiarity does not seem to be ascribable to the level of the classical coronary risk factors in France. Thus, the incidence of ischaemic heart diseases observed in the Parisian Prospective Study is much lower than that of similar American studies, even after adjustment to risk factor levels. The dietary lipid intake of the French seems to be about the same as that of nationals of high coronary mortality countries. The French paradox lies in the contrast between a food rich in saturated fatty acids and a moderate coronary mortality rate, fairly similar to that observed in Mediterranean countries where the dietary fat intake is much smaller than in France. The high mean level of alcohol consumption in France might be one of the factors responsible for this French peculiarity.

Entities:  

Mesh:

Year:  1987        PMID: 3113393

Source DB:  PubMed          Journal:  Arch Mal Coeur Vaiss        ISSN: 0003-9683


  17 in total

1.  Why mortality from heart disease is low in France. Rates of coronary events are similar in France and Southern Europe.

Authors:  P Ducimetière; T Lang; P Amouyel; D Arveiler; J Ferrières
Journal:  BMJ       Date:  2000-01-22

Review 2.  Is wine good for your heart? A critical review.

Authors:  N Gall
Journal:  Postgrad Med J       Date:  2001-03       Impact factor: 2.401

Review 3.  Resveratrol and resveratrol analogues--structure-activity relationship.

Authors:  Thomas Szekeres; Monika Fritzer-Szekeres; Philipp Saiko; Walter Jäger
Journal:  Pharm Res       Date:  2010-03-16       Impact factor: 4.200

Review 4.  Chemosensitization of tumors by resveratrol.

Authors:  Subash C Gupta; Ramaswamy Kannappan; Simone Reuter; Ji Hye Kim; Bharat B Aggarwal
Journal:  Ann N Y Acad Sci       Date:  2011-01       Impact factor: 5.691

5.  Resveratrol derivatives as promising chemopreventive agents with improved potency and selectivity.

Authors:  Tamara P Kondratyuk; Eun-Jung Park; Laura E Marler; Soyoun Ahn; Yang Yuan; Yongsoo Choi; Rui Yu; Richard B van Breemen; Bin Sun; Juma Hoshino; Mark Cushman; Katherine C Jermihov; Andrew D Mesecar; Clinton J Grubbs; John M Pezzuto
Journal:  Mol Nutr Food Res       Date:  2011-06-29       Impact factor: 5.914

Review 6.  The Oxygen Paradox, the French Paradox, and age-related diseases.

Authors:  Joanna M S Davies; Josiane Cillard; Bertrand Friguet; Enrique Cadenas; Jean Cadet; Rachael Cayce; Andrew Fishmann; David Liao; Anne-Laure Bulteau; Frédéric Derbré; Amélie Rébillard; Steven Burstein; Etienne Hirsch; Robert A Kloner; Michael Jakowec; Giselle Petzinger; Delphine Sauce; Florian Sennlaub; Isabelle Limon; Fulvio Ursini; Matilde Maiorino; Christina Economides; Christian J Pike; Pinchas Cohen; Anne Negre Salvayre; Matthew R Halliday; Adam J Lundquist; Nicolaus A Jakowec; Fatima Mechta-Grigoriou; Mathias Mericskay; Jean Mariani; Zhenlin Li; David Huang; Ellsworth Grant; Henry J Forman; Caleb E Finch; Patrick Y Sun; Laura C D Pomatto; Onnik Agbulut; David Warburton; Christian Neri; Mustapha Rouis; Pierre Cillard; Jacqueline Capeau; Jean Rosenbaum; Kelvin J A Davies
Journal:  Geroscience       Date:  2017-12-21       Impact factor: 7.713

7.  Autres pays, autres moeurs.

Authors:  H Tunstall-Pedoe
Journal:  BMJ       Date:  1988-12-17

Review 8.  Resveratrol and red wine, healthy heart and longevity.

Authors:  Dipak K Das; Subhendu Mukherjee; Diptarka Ray
Journal:  Heart Fail Rev       Date:  2010-09       Impact factor: 4.214

9.  Dose-dependency of resveratrol in providing health benefits.

Authors:  Subhendu Mukherjee; Jocelyn I Dudley; Dipak K Das
Journal:  Dose Response       Date:  2010-03-18       Impact factor: 2.658

10.  Multifactorial anticancer effects of digalloyl-resveratrol encompass apoptosis, cell-cycle arrest, and inhibition of lymphendothelial gap formation in vitro.

Authors:  S Madlener; P Saiko; C Vonach; K Viola; N Huttary; N Stark; R Popescu; M Gridling; N T-P Vo; I Herbacek; A Davidovits; B Giessrigl; S Venkateswarlu; S Geleff; W Jäger; M Grusch; D Kerjaschki; W Mikulits; T Golakoti; M Fritzer-Szekeres; T Szekeres; G Krupitza
Journal:  Br J Cancer       Date:  2010-04-27       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.